Does beta-blocker treatment influence central sleep apnoea? - 15/08/11
, Tobias Welte
Corresponding author. Tel.: +495115323533; fax: +495115328532.Summary |
Chronic severe heart failure is frequently associated with disturbances in the central control of breathing. During wakefulness, central breathing disorders could be ameliorated with beta-blocker treatment, but nothing is known about the effects of beta-blockers on the control of breathing during sleep. This study intends to determinate the prevalence and severity of nocturnal apnoeas and hypopnoeas in heart failure patients treated with or without metoprolol or carvedilol.
Fifty consecutive patients with dilated cardiomyopathy in NYHA class II–IV with a left ventricular ejection fraction (LVEF) of 35% or below were studied with full polysomnography over one night.
The mean Apnoea–Hypopnoea Index of beta-blocker free patients was 19.8±14.2 versus 7.4±8.5 (p<0.05) and 8.7±8.1 (p<0.05) in patients treated with metoprolol or carvedilol, respectively. The arousal index, sleep quality, and daytime sleepiness were improved in similar magnitude.
Conclusion |
Long-term treatment of patients with advanced chronic heart failure with sufficient doses of metoprolol or carvedilol is associated with a lower prevalence and severity of central sleep apnoea (CSA).
Le texte complet de cet article est disponible en PDF.Keywords : Beta-blocker, Central sleep apnoea, Cheyne–Stokes respiration, Heart failure
Plan
Vol 101 - N° 4
P. 850-853 - avril 2007 Retour au numéro
Article précédent
- Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: A randomized, double blind, single-dose, crossover study
- A. Jantikar, B. Brashier, M. Maganji, A. Raghupathy, P. Mahadik, P. Gokhale, J. Gogtay, S. Salvi
- Idiopathic pulmonary arterial hypertension in Dutch Caucasian patients is not associated with human herpes virus-8 infection
- Paul Bresser, Marion I. Cornelissen, Wim van der Bij, Carel J.M. van Noesel, Wim Timens
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?